The Goldman Sachs Group began coverage on shares of Doximity (NASDAQ:DOCS – Free Report) in a report issued on Friday, Marketbeat Ratings reports. The brokerage issued a neutral rating and a $58.00 price target on the stock.
DOCS has been the topic of a number of other research reports. Wells Fargo & Company upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and upped their price objective for the stock from $19.00 to $41.00 in a report on Friday, November 8th. Bank of America boosted their target price on Doximity from $32.00 to $45.00 and gave the stock a “neutral” rating in a report on Monday, October 7th. Truist Financial lifted their price target on Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a research report on Thursday. Canaccord Genuity Group reissued a “hold” rating and set a $60.00 price objective (up from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. Finally, Evercore ISI lifted their target price on shares of Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Eleven equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Doximity currently has a consensus rating of “Hold” and an average price target of $51.07.
Check Out Our Latest Research Report on DOCS
Doximity Trading Down 5.1 %
Institutional Trading of Doximity
Several large investors have recently modified their holdings of the company. Farther Finance Advisors LLC boosted its position in Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after purchasing an additional 603 shares during the last quarter. LRI Investments LLC purchased a new position in shares of Doximity in the first quarter worth approximately $27,000. Morse Asset Management Inc purchased a new position in shares of Doximity in the third quarter worth approximately $46,000. Blue Trust Inc. grew its position in Doximity by 621.4% during the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after buying an additional 1,193 shares during the period. Finally, GAMMA Investing LLC increased its holdings in Doximity by 40.1% during the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after buying an additional 412 shares during the last quarter. Institutional investors own 87.19% of the company’s stock.
About Doximity
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories
- Five stocks we like better than Doximity
- The How And Why of Investing in Oil Stocks
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What Are Dividend Achievers? An Introduction
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Best Stocks Under $10.00
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.